Literature DB >> 28723142

What Are Clinically Relevant Levels of Cellular and Biomolecular Analytes?

Shana O Kelley1.   

Abstract

The ultimate goal of developing sensors for biomolecular analytes is to offer new tools for the analysis of clinical specimens for biomarkers of disease. It is thus important to understand the types of samples that are routinely used in the clinic for specific indications, and what the typical levels of relevant analytes are in these specimens. This Sensor Issues article summarizes information concerning levels of target molecules and cells that are of interest for the development of new diagnostics for infectious disease and cancer. Having this information in hand helps better define the "needle-in-a-haystack" challenge associated with developing robust sensors with the needed levels of sensitivity and specificity.

Entities:  

Keywords:  DNA detection; bioanalysis; cancer; clinical samples; infectious disease; protein detection

Year:  2017        PMID: 28723142     DOI: 10.1021/acssensors.6b00691

Source DB:  PubMed          Journal:  ACS Sens        ISSN: 2379-3694            Impact factor:   7.711


  24 in total

1.  Novel epoxy-silica nanoparticles to develop non-enzymatic colorimetric probe for analytical immuno/bioassays.

Authors:  Chandra K Dixit; Snehasis Bhakta; John Macharia; Jared Furtado; Steven L Suib; James F Rusling
Journal:  Anal Chim Acta       Date:  2018-04-24       Impact factor: 6.558

2.  Development of an Electrochemical Paper-Based Analytical Device for Trace Detection of Virus Particles.

Authors:  Robert B Channon; Yuanyuan Yang; Kristen M Feibelman; Brian J Geiss; David S Dandy; Charles S Henry
Journal:  Anal Chem       Date:  2018-06-01       Impact factor: 6.986

3.  Universal amplification-free molecular diagnostics by billion-fold hierarchical nanofluidic concentration.

Authors:  Wei Ouyang; Jongyoon Han
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-29       Impact factor: 11.205

Review 4.  Electrochemical biosensors for pathogen detection.

Authors:  Ellen Cesewski; Blake N Johnson
Journal:  Biosens Bioelectron       Date:  2020-04-12       Impact factor: 10.618

5.  First characterization of a biphasic, switch-like DNA amplification.

Authors:  Burcu Özay; Cara M Robertus; Jackson L Negri; Stephanie E McCalla
Journal:  Analyst       Date:  2018-04-16       Impact factor: 4.616

6.  One-Step Nucleic Acid Purification and Noise-Resistant Polymerase Chain Reaction by Electrokinetic Concentration for Ultralow-Abundance Nucleic Acid Detection.

Authors:  Wei Ouyang; Jongyoon Han
Journal:  Angew Chem Int Ed Engl       Date:  2020-04-30       Impact factor: 15.336

7.  Building with intent: technologies and principles for engineering mammalian cell-based therapies to sense and respond.

Authors:  Joseph J Muldoon; Patrick S Donahue; Taylor B Dolberg; Joshua N Leonard
Journal:  Curr Opin Biomed Eng       Date:  2017-10-18

8.  Solid-Phase Microextraction Enables Isolation of BRAF V600E Circulating Tumor DNA from Human Plasma for Detection with a Molecular Beacon Loop-Mediated Isothermal Amplification Assay.

Authors:  Marcelino Varona; Derek R Eitzmann; Darshna Pagariya; Robbyn K Anand; Jared L Anderson
Journal:  Anal Chem       Date:  2020-01-28       Impact factor: 6.986

9.  Electrode-Free Concentration and Recovery of DNA at Physiologically Relevant Ionic Concentrations.

Authors:  Sixuan Li; Andrew Li; Kuangwen Hsieh; Sarah M Friedrich; Tza-Huei Wang
Journal:  Anal Chem       Date:  2020-04-13       Impact factor: 8.008

10.  Graphene/gold nanoparticle composites for ultrasensitive and versatile biomarker assay using single-particle inductively-coupled plasma/mass spectrometry.

Authors:  Yuqian Xing; Juan Han; Xu Wu; David T Pierce; Julia Xiaojun Zhao
Journal:  Analyst       Date:  2021-01-07       Impact factor: 4.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.